Product Information
SKYRIZI 150 MG/ML PEN is a brand product labeled by AbbVie Inc., priced at $22710.1121 per ML under NDC 00074210001. Its NADAC has been published 188 times since Nov 23, 2022.
Strength
150 mg/mL
Manufacturer
AbbVie Inc.NDC
00074210001
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
RISANKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761105On Market Since
4/26/2021
Pharmacological Classes
Price Statistics
The NADAC for SKYRIZI 150 MG/ML PEN has been published 188 times since Nov 23, 2022, and over the history we have for it it has risen 28.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22710.1121 per ML |
|---|---|
| All-time high | $22807.6858 (May 13, 2026) |
| All-time low | $17642.3820 (Dec 21, 2022) |
| 52-week high | $22807.6858 |
| 52-week low | $21408.4649 |
| Median price | $20292.2678 |
| Average price | $20494.7133 |
| Largest weekly change | +8.0% (Jan 11, 2023) |
| Weeks tracked | 188 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SKYRIZI 150 MG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for SKYRIZI 150 MG/ML PEN, manufactured by AbbVie Inc., is $22710.1121 per ML (NDC 00074210001), effective Jun 24, 2026.
How has the price of SKYRIZI 150 MG/ML PEN changed over time?
Over the history we have for it, the NADAC for SKYRIZI 150 MG/ML PEN has risen 28.3%. It has been tracked across 188 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for SKYRIZI 150 MG/ML PEN?
Since Nov 23, 2022, the NADAC for SKYRIZI 150 MG/ML PEN has ranged from a low of $17642.3820 (Dec 21, 2022) to a high of $22807.6858 (May 13, 2026), with a median of $20292.2678 per ML.
Are there cheaper alternatives to SKYRIZI 150 MG/ML PEN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SKYRIZI 150 MG/ML PEN, but none are currently priced below it.
Who manufactures SKYRIZI 150 MG/ML PEN?
SKYRIZI 150 MG/ML PEN (NDC 00074210001) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification